# SXTP (60 Degrees Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> 60 Degrees Pharmaceuticals, Inc. reported $907K in revenue and a net loss of $8.35M for the trailing twelve months ended September 30, 2026 (down 46.7% year over year), with a 24.1% gross margin and a -971.7% operating margin.

- Canonical: https://convexityos.com/fundamentals/SXTP
- Markdown: https://convexityos.com/fundamentals/SXTP.md
- SEC CIK: 0001946563
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:12 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001946563&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $907K | -46.7% YoY |
| Operating Income | TTM | -$8.81M | -971.7% margin |
| Net Income | TTM | -$8.35M | -921.0% net margin |
| Diluted EPS | TTM | -$2.35 | Split-adjusted |
| Free Cash Flow | TTM | -$8.22M | -906.9% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $306K | Total debt: $150K |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Revenue** | $1.01M | $608K | $254K | $223K |
| Cost of Revenue | $782K | $385K | $475K | $432K |
| **Gross Profit** | $224K | $223K | -$221K | -$209K |
| Research & Development | $2.11M | $4.99M | $692K | $526K |
| Total Operating Expenses | $8.39M | $10.01M | $4.93M | $1.83M |
| **Operating Income** | -$7.76M | -$9.72M | -$5.15M | -$1.75M |
| **EBITDA** | -$7.72M | -$9.70M | -$5.13M | -$1.72M |
| Interest Expense | $7.8K | $7.9K | $2.29M | $3.99M |
| Income Before Tax | -$7.37M | -$7.96M | -$3.81M | -$6.18M |
| Income Tax Expense | $0 | $0 | $250 | $500 |
| **Net Income** | -$7.37M | -$7.95M | -$3.77M | -$6.18M |
| Basic EPS | -$11.73 | -$74.17 | -$1,183.60 | -$37,523.99 |
| **Diluted EPS** | -$11.73 | -$74.17 | -$1,183.60 | -$37,523.99 |
| Basic Shares Outstanding | 670.2K | 113.7K | 3.3K | 165 |
| Diluted Shares Outstanding | 670.2K | 113.7K | 3.3K | 165 |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $233K | $208K | $162K | $303K | $438K | $101K | $164K | $242K |
| Cost of Revenue | $331K | $151K | $86K | $121K | $538K | $50K | $73K | $118K |
| **Gross Profit** | -$98K | $57K | $76K | $183K | -$100K | $51K | $90K | $124K |
| Research & Development | $783K | $599K | $281K | $717K | $786K | $232K | $371K | $614K |
| Total Operating Expenses | $2.43M | $2.33M | $2.17M | $2.11M | $2.32M | $1.86M | $2.09M | $2.22M |
| **Operating Income** | -$2.53M | -$2.27M | -$2.09M | -$1.92M | -$2.33M | -$1.61M | -$1.91M | -$2.07M |
| **EBITDA** | -$2.51M | -$2.25M | -$2.08M | -$1.90M | -$2.31M | -$1.60M | -$1.90M | -$2.06M |
| Interest Expense | $1.4K | $1.4K | $1.4K | $3.1K | $1.7K | $1.2K | $1.8K | $1.4K |
| Income Before Tax | -$2.56M | -$2.27M | -$2.09M | -$1.44M | -$2.32M | -$1.73M | -$1.88M | -$2.05M |
| Income Tax Expense | -- | -- | -- | -$1.8K | $250 | $1.5K | $63 | -$751 |
| **Net Income** | -$2.56M | -$2.26M | -$2.09M | -$1.44M | -$2.32M | -$1.73M | -$1.88M | -$2.05M |
| Basic EPS | -$0.75 | -$0.90 | -$1.28 | -- | -$2.66 | -$5.01 | -$6.25 | -- |
| **Diluted EPS** | -$0.75 | -$0.90 | -$1.28 | -- | -$2.66 | -$5.01 | -$6.25 | -- |
| Basic Shares Outstanding | 3.6M | 2.7M | 1.7M | -- | 918.9K | 368.2K | 320.9K | -- |
| Diluted Shares Outstanding | 3.6M | 2.7M | 1.7M | -- | 918.9K | 368.2K | 320.9K | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.51M | $1.66M | $2.14M | $265K |
| Short-Term Investments | $1.24M | $1.73M | -- | -- |
| **Cash & Short-Term Investments** | $2.75M | $3.39M | $2.14M | $265K |
| Accounts Receivable, Net | $510K | $487K | $231K | $46K |
| Inventory | $657K | $443K | $466K | $519K |
| **Total Current Assets** | $4.90M | $5.39M | $7.24M | $1.10M |
| Property, Plant & Equipment, Net | $246K | $150K | $58K | $21K |
| Intangible Assets | $224K | $157K | $227K | $164K |
| Other Non-Current Assets | $224K | $223K | $483K | -- |
| **Total Non-Current Assets** | $471K | $373K | $541K | $198K |
| **Total Assets** | $5.37M | $5.76M | $7.78M | $1.30M |
| Accounts Payable | $668K | -- | -- | -- |
| Short-Term Debt | $12K | $8.8K | $8.8K | -- |
| **Total Current Liabilities** | $1.85M | $1.66M | $2.84M | $23.92M |
| Long-Term Debt | $144K | $147K | $141K | $16.86M |
| **Total Non-Current Liabilities** | $141K | $147K | $150K | $1.53M |
| **Total Liabilities** | $1.99M | $1.80M | $2.99M | $25.45M |
| **Total Debt (incl. Leases)** | $156K | $156K | $164K | $16.87M |
| Common Stock | $116 | $14 | $10 | $239 |
| Retained Earnings | -$47.89M | -$40.53M | -$32.58M | -$28.82M |
| Accumulated Other Comp. Income | $143K | $135K | $136K | $74K |
| **Total Stockholders' Equity** | $3.46M | $4.04M | $4.87M | -$23.58M |
| Total Equity | $3.38M | $3.96M | $4.80M | -$24.15M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $306K | $1.02M | $3.34M | $1.51M | $4.12M | $1.97M | $3.45M | $1.66M |
| Short-Term Investments | -- | -- | -- | $1.24M | $0 | $0 | -- | $1.73M |
| **Cash & Short-Term Investments** | $306K | $1.02M | $3.34M | $2.75M | $4.12M | $1.97M | $3.45M | $3.39M |
| Accounts Receivable, Net | $338K | $567K | $336K | $510K | $674K | $295K | $488K | $487K |
| Inventory | $579K | $878K | $911K | $657K | $527K | $799K | $773K | $443K |
| **Total Current Assets** | $2.56M | $3.73M | $6.26M | $4.90M | $6.31M | $3.84M | $5.65M | $5.39M |
| Property, Plant & Equipment, Net | $226K | $243K | $260K | $246K | $228K | $194K | $156K | $150K |
| Intangible Assets | $304K | $309K | $243K | $224K | $152K | $144K | $150K | $157K |
| Other Non-Current Assets | $304K | $309K | $243K | $224K | $152K | $144K | $172K | $223K |
| **Total Non-Current Assets** | $530K | $551K | $503K | $471K | $380K | $338K | $328K | $373K |
| **Total Assets** | $3.09M | $4.28M | $6.76M | $5.37M | $6.69M | $4.18M | $5.98M | $5.76M |
| Accounts Payable | $1.15M | -- | -- | $668K | -- | -- | -- | -- |
| Short-Term Debt | $3.6K | $2.0K | $8.8K | $12K | $8.8K | $8.8K | $8.8K | $8.8K |
| **Total Current Liabilities** | $2.19M | $1.61M | $1.88M | $1.85M | $2.20M | $1.69M | $1.80M | $1.66M |
| Long-Term Debt | $146K | $148K | $141K | $144K | $141K | $141K | $141K | $147K |
| **Total Non-Current Liabilities** | $147K | $149K | $143K | $141K | $145K | $145K | $147K | $147K |
| **Total Liabilities** | $2.34M | $1.75M | $2.02M | $1.99M | $2.34M | $1.84M | $1.95M | $1.80M |
| **Total Debt (incl. Leases)** | $150K | $150K | $150K | $156K | $150K | $150K | $150K | $156K |
| Common Stock | $390 | $264 | $264 | $116 | $410 | $147 | $147 | $14 |
| Retained Earnings | -$54.80M | -$52.25M | -$49.98M | -$47.89M | -$46.45M | -$44.14M | -$42.40M | -$40.53M |
| Accumulated Other Comp. Income | $154K | $151K | $149K | $143K | $144K | $143K | $126K | $135K |
| **Total Stockholders' Equity** | $842K | $2.61M | $4.83M | $3.46M | $4.43M | $2.43M | $4.11M | $4.04M |
| Total Equity | $756K | $2.53M | $4.74M | $3.38M | $4.35M | $2.35M | $4.03M | $3.96M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| Net Income | -$7.37M | -$7.96M | -$3.81M | -$6.18M |
| Depreciation & Amortization | $43K | $12K | $21K | $33K |
| Stock-Based Compensation | $456K | $3.61M | $213K | $0 |
| Change in Receivables | -$23K | -$255K | -$185K | $100K |
| Change in Inventory | -$466K | $23K | $213K | $10K |
| **Operating Cash Flow** | -$6.85M | -$5.65M | -$4.54M | -$1.01M |
| Capital Expenditure | -$140K | -$104K | -$58K | -- |
| **Free Cash Flow** | -$6.99M | -$5.75M | -$4.60M | -- |
| **Investing Cash Flow** | $255K | -$1.89M | -$116K | -$60K |
| Common Stock Issued | -- | -- | $1.05M | $1.05M |
| **Financing Cash Flow** | $6.44M | $7.05M | $6.47M | $1.22M |
| **Net Change in Cash** | -$149K | -$483K | $1.88M | $149K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.56M | -$2.27M | -$2.09M | -$1.44M | -$2.32M | -$1.73M | -$1.88M | -$2.05M |
| Depreciation & Amortization | $17K | $17K | $17K | $15K | $12K | $9.2K | $6.7K | $5.4K |
| Stock-Based Compensation | $48K | $98K | $124K | $112K | $79K | $79K | $187K | $62K |
| Change in Receivables | $229K | -$231K | $174K | $164K | -$379K | $193K | -$1.5K | -$163K |
| Change in Inventory | -$204K | $33K | -$2.0K | -$137K | $28K | -$26K | -$330K | $9.3K |
| **Operating Cash Flow** | -$1.45M | -$2.23M | -$2.74M | -$1.69M | -$2.11M | -$1.45M | -$1.60M | -$1.64M |
| Capital Expenditure | $0 | $0 | -$30K | -$80K | -$10.0K | -$47K | -$2.7K | -- |
| **Free Cash Flow** | -$1.45M | -$2.23M | -$2.77M | -$1.77M | -$2.12M | -$1.50M | -$1.60M | -- |
| **Investing Cash Flow** | -$13K | -$86K | $1.19M | -$1.37M | -$25K | -$52K | $1.70M | -$2.1K |
| **Financing Cash Flow** | $740K | $0 | $3.37M | $459K | $4.28M | $0 | $1.70M | $973 |
| **Net Change in Cash** | -$716K | -$2.32M | $1.83M | -$2.61M | $2.15M | -$1.48M | $1.79M | -$1.64M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
| --- | --- | --- | --- | --- |
| **Gross Margin** | 22.3% | 36.7% | -87.1% | -93.7% |
| **Operating Margin** | -771.6% | -1599.0% | -2032.8% | -784.2% |
| **Net Profit Margin** | -732.5% | -1308.0% | -1485.1% | -2769.5% |
| Return on Equity (ROE) | -212.7% | -196.9% | -77.3% | -- |
| Return on Assets (ROA) | -137.3% | -138.0% | -48.4% | -476.5% |
| Current Ratio | 2.65x | 3.25x | 2.55x | 0.05x |
| Quick Ratio | 2.30x | 2.98x | 2.39x | 0.02x |
| Debt to Equity | 0.04x | 0.04x | 0.03x | -- |
| **Revenue Growth (YoY)** | +65.5% | +139.6% | +13.6% | -- |
| Gross Profit Growth (YoY) | +0.4% | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Gross Margin** | 24.1% | 19.4% | 20.9% | 22.3% | 17.4% | 45.0% | 41.0% | 36.7% |
| **Operating Margin** | -971.7% | -774.8% | -791.1% | -771.6% | -838.0% | -1200.7% | -1545.4% | -1599.0% |
| **Net Profit Margin** | -921.0% | -729.9% | -754.8% | -732.5% | -844.7% | -1218.4% | -1540.9% | -1308.0% |
| Return on Equity (ROE) | -991.6% | -310.2% | -156.9% | -212.7% | -179.9% | -321.8% | -249.5% | -196.9% |
| Return on Assets (ROA) | -269.9% | -189.3% | -112.0% | -137.3% | -119.2% | -186.9% | -171.5% | -138.0% |
| Current Ratio | 1.17x | 2.32x | 3.34x | 2.65x | 2.87x | 2.27x | 3.13x | 3.25x |
| Quick Ratio | 0.91x | 1.78x | 2.85x | 2.30x | 2.63x | 1.80x | 2.71x | 2.98x |
| Debt to Equity | 0.18x | 0.06x | 0.03x | 0.04x | 0.03x | 0.06x | 0.04x | 0.04x |
| **Revenue Growth (YoY)** | -46.7% | +106.0% | -0.9% | +25.6% | +223.4% | -19.2% | +54.8% | +92.3% |
| Gross Profit Growth (YoY) | -- | +11.6% | -15.4% | +47.9% | -524.0% | +43.7% | +124.4% | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -535.9% | -- |
| EPS Growth (YoY) | -- | -- | -- | -- | -- | -- | -117.1% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
